These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 19340703

  • 1. Parenteral administration of progestins for hormonal replacement therapy.
    Nath A, Sitruk-Ware R.
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):88-96. PubMed ID: 19340703
    [Abstract] [Full Text] [Related]

  • 2. Routes of delivery for progesterone and progestins.
    Sitruk-Ware R.
    Maturitas; 2007 May 20; 57(1):77-80. PubMed ID: 17368973
    [Abstract] [Full Text] [Related]

  • 3. New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation.
    Sitruk-Ware R.
    Climacteric; 2007 Oct 20; 10(5):358-70. PubMed ID: 17852138
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 20; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hormone therapy and the cardiovascular system: the critical role of progestins.
    Sitruk-Ware RL.
    Climacteric; 2003 Oct 20; 6 Suppl 3():21-8. PubMed ID: 15018245
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The use of newer progestins for contraception.
    Sitruk-Ware R, Nath A.
    Contraception; 2010 Nov 20; 82(5):410-7. PubMed ID: 20933114
    [Abstract] [Full Text] [Related]

  • 14. Pharmacologic characteristics of progestins used for contraception and hormone replacement therapy, including new transdermal technologies.
    Burkman RT.
    Am J Manag Care; 2001 Nov 20; 7(18 Suppl):S571-4. PubMed ID: 11727395
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hormonal contraceptive discontinuation patterns according to formulation: investigation of associations in an administrative claims database.
    Murphy PA, Brixner D.
    Contraception; 2008 Apr 20; 77(4):257-63. PubMed ID: 18342648
    [Abstract] [Full Text] [Related]

  • 17. Considerations in the choice of oral vs. transdermal hormone therapy: a review.
    Minkin MJ.
    J Reprod Med; 2004 Apr 20; 49(4):311-20. PubMed ID: 15134159
    [Abstract] [Full Text] [Related]

  • 18. High C-reactive protein levels are associated with oral hormonal menopausal therapy but not with intrauterine levonorgestrel and transdermal estradiol.
    Blumenfeld Z, Boulman N, Leiba R, Siegler E, Shachar S, Linn R, Levy Y.
    Scand J Clin Lab Invest; 2007 Apr 20; 67(3):257-63. PubMed ID: 17454839
    [Abstract] [Full Text] [Related]

  • 19. Transdermal natural progesterone cream for postmenopausal women: inconsistent data and complex pharmacokinetics.
    Elshafie MA, Ewies AA.
    J Obstet Gynaecol; 2007 Oct 20; 27(7):655-9. PubMed ID: 17999287
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.